Pregnancy Clinical Trial
Official title:
Randomised, Double-blind, Phase IV Study to Compare the Incidence of ECG Changes During Elective Caesarean Section Under Spinal Anaesthesia When Using Phenylephrine or Ephedrine Infusion to Maintain Baseline Systolic Blood Pressure
ECG changes during caesarean section are common. Incidence of ST depression on the ECG is up
to 81% in some studies. Although this may indicate inadequate oxygen supply to the heart
muscle (myocardial ischaemia) many other theories have been suggested including air entering
the circulation from the placental bed, high heart rate, hormone or nervous system
influences and spasm of the coronary blood supply. Perioperative ST depression often
reflects an imbalance between heart muscle oxygen supply and demand. At the time of
delivery, high heart rate is common and there is a further increase in the amount of blood
the heart has to pump every minute due to blood coming back to the circulation from the
placental bed. This increases oxygen demand and most ST changes are seen at the time of
delivery or within 30 minutes. The clinical significance of these changes is much debated,
and apart from a few case reports do not appear to be associated with poor heart muscle
function or ischaemia (lack of oxygen supply). Management of the mother's blood pressure
during caesarean section has changed greatly in recent years. Intermittent boluses of
ephedrine, given when blood pressure is low, have been replaced with prevention of low blood
pressure and phenylephrine has become the drug of choice. Ephedrine increases heart rate and
contractility of the heart muscle and is likely to increase oxygen demand. Phenylephrine
reduces heart rate while maintaining blood pressure which may result in a more favorable
oxygen supply demand ratio.
The investigators aim to compare the incidence of ECG changes if the mother's blood pressure
is maintained with phenylephrine as compared to ephedrine. To see if these ECG changes are
associated with myocardial ischaemia, the investigators will perform troponin T analysis
after delivery. Troponin T is a molecule released by ischaemic heart muscle.
Status | Terminated |
Enrollment | 29 |
Est. completion date | January 2016 |
Est. primary completion date | January 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: 1. Able to give written informed consent 2. >37/40 weeks gestation 3. Singleton pregnancy 4. Elective caesarean section under spinal anaesthesia 5. In good general health (American Society of Anesthesiology Category 1 or 2, fit and well or with mild systemic disease that has no impact on physical activity ) Exclusion Criteria: 1. Circulatory disease (eg pre-existing hypertension) 2. Cardiac disease/medications (e.g. angina, cardiomyopathy, B Blocker medication) 3. Pregnancy related disease (eg pre-eclampsia) 4. Diabetes pre-existing the pregnancy 5. Hyperthyroidism 6. Renal Disease 7. Closed-angle glaucoma 8. Patients on monoamine oxidase inhibitors 9. In active labour 10. Emergency caesarean section 11. Fetal abnormalities 12. Contraindications to spinal anaesthesia 13. Height >6 feet/180cm / Height <5 feet/150cm 14. Body mass index (BMI) <19 or >35 |
Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
United Kingdom | University College London Hospital | London |
Lead Sponsor | Collaborator |
---|---|
University College London Hospitals | Obstetric Anaesthetists' Association |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | ST segment changes on Holter monitoring | 30 minutes pre spinal anaesthesia to 4 hours post delivery | No | |
Secondary | Troponin levels | 24h post delivery | No | |
Secondary | Incidence of maternal low systolic blood pressure | 20 minutes post spinal and 30 minutes post delivery | No | |
Secondary | Maternal cardiac output | 20 minutes post spinal and one measure at 5 minutes post delivery | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Completed |
NCT02408315 -
Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium (IMPROVE)
|
Phase 3 |